Uterine papillary serous carcinoma

Area of Science:

• Gynecologic Oncology
• Pathology
• Clinical Medicine

Background:

• Uterine papillary serous carcinoma (UPSC) is a rare and aggressive subtype of endometrial cancer.
• UPSC is associated with a poorer prognosis compared to endometrioid endometrial cancer.

Purpose of the Study:

• To review the clinical presentation, surgical findings, treatment outcomes, and survival rates of patients diagnosed with uterine papillary serous carcinoma.
• To evaluate the effectiveness of different treatment modalities, including surgery, radiation therapy, and chemotherapy, in managing UPSC.

Main Methods:

• Retrospective review of 37 patients diagnosed with uterine papillary serous carcinoma.
• Analysis of clinical staging, surgical findings (including myometrial and lymphatic invasion), and treatment received (surgery, radiation, chemotherapy).
• Evaluation of patient survival rates and disease recurrence based on stage and treatment received.

Main Results:

• High rates of pelvic and extra-pelvic metastases were observed in clinical stages I and II UPSC.
• Significant myometrial invasion (≥50%) and lymphatic invasion were common findings in hysterectomy specimens.
• Adjuvant radiation therapy for surgical stage I/II UPSC showed promising disease-free survival (9/10 alive).
• Combination chemotherapy, particularly cis-platinum-based regimens, demonstrated limited efficacy with high mortality and progressive disease rates.

Conclusions:

• Early detection and surgical staging are crucial for managing uterine papillary serous carcinoma.
• Adjuvant radiation therapy appears beneficial for early-stage UPSC, improving survival and disease-free status.
• Current combination chemotherapy regimens show limited effectiveness for advanced UPSC, necessitating further research into novel therapeutic strategies.